Jinxin Fertility Group Limited
HKSE: 1951.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Yang Dong
- Employees
- 3,198
- Headquarters
- Chengdu, China
- IPO year
- 2019
- Market cap
- HK$6.4B
- Website
- https://www.jxr-fertility.com
Loading 1951…
Loading profile data…Frequently asked questions about 1951
What does Jinxin Fertility Group Limited (1951.HK) do?
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved...
Where does 1951.HK trade?
Jinxin Fertility Group Limited (1951.HK) trades on the Hong Kong Stock Exchange.
What sector is 1951.HK in?
Jinxin Fertility Group Limited (1951.HK) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of Jinxin Fertility Group Limited?
Yang Dong is the chief executive officer of Jinxin Fertility Group Limited (1951.HK).
Where is Jinxin Fertility Group Limited headquartered?
Jinxin Fertility Group Limited is headquartered in China.
Does 1951.HK pay a dividend?
Yes — Jinxin Fertility Group Limited (1951.HK) paid a trailing twelve-month dividend of HKD 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1951.HK go public?
Jinxin Fertility Group Limited (1951.HK) completed its initial public offering in 2019.